The goals of this proposal are to understand the mechanisms of viral entry into cells in the polyoma virus-mouse system. Important determinants of virus pathogenicity have been mapped to VP1, the major viral capsid protein. Attachment of virus to target cells in the host are mediated by unknown glycoproteins with specific sialic acid linkages. We will attempt to identify the cell attachment proteins that mediate virus entry, using several approaches. Mouse cell lines lacking functional receptor(s) will be identified on the basis of being resistant to viral infection but susceptible to viral DNA transfection. These lines will be transfected with cDNA expression libraries prepared from mouse tissues that are rich in receptors(s), and selected for virus susceptibility. To permit a direct positive selection for receptor- positive transfectants, a polyoma DNA vector encoding a Hygromycin- resistance gene in the place of VP1 will be constructed. Packaging of this vector will be attempted using a Sindbis-VP1 helper virus. Immunological approaches will be used involving screening for rat-anti- mouse cell monoclonal antibodies that protect against viral infection. Site-directed mutagenesis on regions of VP1 likely to be involved in cell binding and entry will be carried out. Finally, histological and biochemical approaches will be pursued to identify a class of natural inhibitors, or pseudoreceptors, in the mouse that prevent spread by certain strains of polyoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA050661-10
Application #
6269421
Study Section
Project Start
1998-03-06
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Becker, Jürgen C; Stang, Andreas; Hausen, Axel Zur et al. (2018) Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 67:341-351
Becker, Jürgen C; Stang, Andreas; DeCaprio, James A et al. (2017) Merkel cell carcinoma. Nat Rev Dis Primers 3:17077
Denis, Deborah; Rouleau, Cecile; Schaffhausen, Brian S (2017) A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling. J Virol 91:
Starrett, Gabriel J; Marcelus, Christina; Cantalupo, Paul G et al. (2017) Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma. MBio 8:
Cizmecioglu, Onur; Ni, Jing; Xie, Shaozhen et al. (2016) Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. Elife 5:
Rouleau, Cecile; Pores Fernando, Arun T; Hwang, Justin H et al. (2016) Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. J Virol 90:7032-7045
Pores Fernando, A T; Andrabi, S; Cizmecioglu, O et al. (2015) Polyoma small T antigen triggers cell death via mitotic catastrophe. Oncogene 34:2483-92
Berrios, Christian; Jung, Joonil; Primi, Blake et al. (2015) Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors. J Virol 89:857-62
Luo, Leo Y; Kim, Eejung; Cheung, Hiu Wing et al. (2015) The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Mol Cancer Res 13:502-9
Hettmer, Simone; Schinzel, Anna C; Tchessalova, Daria et al. (2015) Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. Elife 4:

Showing the most recent 10 out of 147 publications